The relationship between virus and host cells is multifactorial and nonlinear. This indicates that the effect of an immune response on infection can lead to several different outcomes. These include severe immunopathology. We seek to define properties of CTL-induced pathology in viral infections and examine the implications for HIV disease progression. We find that CTL-induced pathology is observed if the rate of viral replication is fast relative to the CTL responsiveness of the host. Theoretical predictions are consistent with empirical data on LCMV infection. These conditions are also sufficient to induce pathology in HIV infection. However, the absence of HIV-specific CTL can result in an equivalent depletion of the CD4 T cell pool as a consequence of the short life span of activated T cells. A mathematical model describing the evolution of HIV coreceptor usage in the context of lytic and nonlytic CD8 cell responses might account for the relatively long time span required to result in disease. Viral evolution toward parameter ranges allowing CTL-induced pathology is difficult to achieve. It requires the emergence of fast viral replication together with escape from nonlytic CTL responses. However, according to the model, fast viral replication can result in the evolution of virus strains that are susceptible to chemokine-mediated inhibition of viral replication.
INTRODUCTION
In many virus infections, especially with noncytopathic viruses, the lytic CTL response has been shown to be necessary to eliminate or control the disease (Jeffery et al., 1999; Kagi and Hengartner, 1996; Kagi et al., 1995; Saah et al., 1998; Schmitz et al., 1999) . However, at the same time, the lytic CTL response can be detrimental to the host, causing severe immunopathology following the destruction of host cells. The classic case study for such immunopathology is murine LCMV infection (LehmannGrube, 1971 ; Moskophidis et al., 1993; Zinkernagel et al., 1996) . In the absence of a CTL response, for example, during neonatal infection (Moskophidis et al., 1993) or CTL exhaustion (Bocharov, 1998; Moskophidis et al., 1993; Wodarz et al., 1998) , the mouse remains healthy because of the noncytopathic nature of the virus. The presence of an efficient CTL response can successfully control the infection, while less efficient LCMV-specific CTL can lead to severe immunopathological effects, characterized by wasting of the mice (Clark et al., 1995; Matloubian et al., 1999; Moskophidis et al., 1993 Moskophidis et al., , 1995 Zinkernagel et al., 1996 Zinkernagel et al., , 1999 . This is promoted by faster replicating virus strains as well as relatively high inoculum doses (Moskophidis et al., 1995) . These findings are in agreement with a theoretical study showing that tissue damage due to immunopathology is likely to be most severe in hosts characterized by a CTL response of relatively low or intermediate efficacy (Krakauer and Nowak, 1999) .
CTL-mediated immunopathology has also been suggested as a possible reason for the eventual development of AIDS (Zinkernagel, 1994 (Zinkernagel, , 1995 Zinkernagel and Hengartner, 1994; Zinkernagel et al., 1999) . However, the efficacy and role of CTL in HIV infection, as well as the cytotoxicity of the virus, are still highly controversial (Klenerman et al., 1996) . In addition, it is unclear how CTLmediated pathology could account for the depletion of the CD4 ϩ T cell pool, given that during the asymptomatic period of the infection only a small proportion of the overall T cell population is infected and that the replication cycle of the virus cannot be completed in resting T cells (Heinzinger et al., 1994; Stevenson, 1994 Stevenson, , 1996 Stevenson et al., 1995) . Thus, virus-induced bystander killing of uninfected T cells has been proposed to account for the eventual loss of CD4 cells (Banda et al., 1992; Finkel and Banda, 1994; Gougeon et al., 1993a,b; Kameoka et al., 1997) , although theory suggests that this will not be of sufficient magnitude (Krakauer and Nowak, 1999) . Moreover, it is not clear how CTL-mediated pathology as a cause of AIDS can be reconciled with the long time period required to reach the end-stage of the disease.
Here we use mathematical models to further examine the properties of CTL-induced pathology as well as the implications for HIV infection. The interactions between virus, target cells, and the immune system are highly nonlinear. Thus, the equilibrium outcomes of an infection are frequently counterintuitive. Mathematical models take us beyond verbal or graphical reasoning and provide a solid framework upon which to build experiments and generate hypotheses. Based on the models we offer an exact definition of CTL-mediated pathology. We investigate how it might account for T cell depletion in HIVinfected patients and suggest a mechanism for the relatively long phase of disease progression.
RESULTS AND DISCUSSION
What is CTL-induced pathology?
We consider a basic model describing the interaction between the virus, its host cells, and a lytic CTL response. We use this model in order to examine the properties of CTL-induced pathology brought about by direct lysis of target cells by specific CTL. Immunopathology brought about by cytokine production or bystander activation is not analyzed and requires different treatment. The model contains three variables: uninfected cells, x, infected cells, y, and CTL, z. It is described mathematically under Materials and Methods and schematically in Fig. 1 . Since the CTL response is likely to be detrimental to the host if the virus is noncytotoxic (Krakauer and Nowak, 1999) , we examine this scenario assuming that the life span of uninfected cells equals that of infected cells in the absence of immunity (a ϭ d). The degree of CTL-mediated pathology is described in the model by the total number of target cells found in the presence of the virus and the CTL response, i.e., by x
(1) ϩ y (1) (see Materials and Methods). Figure 2 displays the properties of CTL-induced pathology. Pathology is determined mainly by the rate of viral replication relative to the strength of the CTL response. If the CTL responsiveness is low relative to the replication rate of the virus, then the CTL can induce a significant reduction of the total number of target cells. If the CTL responsiveness is high relative to the rate of viral replication, then the CTL do not induce tissue pathology, but contribute to the resolution of the infection. Therefore, the faster the replication rate of the virus, the stronger the CTL response must be in order to have a beneficial effect on the host and to avoid CTL-induced pathology. Thus, with slowly replicating viruses, the lytic CTL response is unlikely to result in high degrees of tissue damage. On the other hand, with fast replicating virus strains, the lytic CTL response is likely to be detrimental. The reason for these patterns is shown in Fig. 3 . If the virus replicates at a fast rate, the CTL suppress the number of infected cells, while the replicating pathogen depletes the number of uninfected cells. On the other hand, for slow viral replication, the number of infected cells is kept at low levels while virus replication fails to deplete the population of uninfected cells.
Although we have explored the properties of CTLinduced pathology assuming a noncytotoxic virus, our results do not strictly depend on this assumption. In general, the presence of a CTL response can lead to a reduction in the total number of target cells if the cytopathicity of the virus is low relative to the rate of viral replication. In terms of the model, CTL can result in tissue damage if a Ͻ (␤) 1/ 2 , where a denotes viral cytopathicity and ␤ correlates with the replication kinetics of the virus (Krakauer and Nowak, 1999) . Therefore, if the virus replicates at a fast rate, CTL can induce pathology even if the virus is relatively cytotoxic.
Based on these findings we can give a definition of CTL-induced pathology. CTL-mediated pathology occurs if the sum of uninfected and infected target cells at equilibrium is smaller in the presence of a CTL response than in the absence of CTL. CTL-induced pathology is not a property of the host alone. It is likely to be observed with viruses that are characterized by a fast rate of replication relative to the rate of virus-induced cytotoxicity. The degree of CTL-induced pathology is promoted by a fast rate of viral replication relative to the CTL responsiveness of the host. In this case, the immune system keeps the number of infected cells at low levels, while the virus reduces the number of uninfected cells.
CTL-induced pathology in LCMV infection
LCMV infection in mice is a major experimental model used to study the properties of CTL-induced pathology. The outcome of LCMV infection depends on a complex balance between host and viral parameters as well as initial conditions. The outcomes of infection include CTLmediated resolution of disease (Zinkernagel, 1993) , CTL exhaustion (Moskophidis et al., 1993; Wodarz et al., 1998) , CTL-induced pathology (Zinkernagel, 1993 (Zinkernagel, , 1996 , and stable coexistence between persistent virus replication and a CTL response (C. Bartholdy, J. P. Christensen, D. Wodarz, and A. R. Thomsen, submitted for publication). CTL-induced pathology has been shown to be dependent on lysis of infected cells and consequent tissue damage (Thomsen et al., in press ). In agreement with our model, experimental data indicate that the occurrence of CTL-induced pathology depends on the rate of viral replication and the strength of the host response (Matloubian et al., 1999; Thomsen et al., in press; Zinkernagel, 1993) . A sufficiently strong CTL response results in resolution of the infection. On the other hand, CTL exhaustion results in persistent viral replication at high loads. Because of the noncytopathic nature of the virus, no tissue damage is observed and the host does not develop any symptoms. On the other hand, a CTL response of intermediate strength can result in severe CTL-induced tissue damage and wasting of the mouse. CTLinduced pathology is most likely to occur with virus strains characterized by fast replication kinetics. In addition, the presence of soluble factors such as IFN-␥, reducing the overall replication rate of the virus, reduces the amount of tissue damage and promotes a beneficial It is an extension of the basic virus infection model to account for the experimental observation that HIV can complete its replication cycle only in activated T cells. We assume that resting T cells are produced at a constant rate and that responsive T cells become activated and thus susceptible to HIV by exposure to viral antigen. We include the possibility of feedback in the activation term. That is, if the value of ⑀ is low, the rate of T cell activation increases if the number of activated T cells falls to low levels. (c) Principles underlying the evolutionary model of HIV coreceptor usage. We assume that HIV can infect mainly two cell types: T cells and macrophages. While T cells can be infected by using either the CCR5 or the CXCR4 coreceptors, macrophages can be infected only by using CCR5. HIV infects CCR5-bearing cells with a probability q and CXCR4-bearing cells with a probability 1 Ϫ q. Hence a value of q ϭ 1 represents complete viral specialization on CCR5, while a value of q ϭ 0 represents complete viral specialization on CXCR4. The CD8 cell response has two modes of antiviral activity. It can lyse infected cells, and in accord with sequence data, we assume that CTL-mediated lysis is directed mainly at T cells. On the other hand, CD8 cells secrete ␤-chemokines that inhibit viral entry into CCR5-bearing cells. The ␤-chemokines do not inhibit infection of virus strains using the CXCR4 coreceptor.
effect of the CTL (Thomsen et al., in press ). With the slowly replicating Armstrong strain, the absence of IFN-␥ does not significantly compromise virus control. Although the virus can replicate persistently in the presence of CTL, significant amounts of CTL-induced pathology are not observed (Thomsen et al., in press ). On the other hand, with the faster replicating Traub strain, the absence of IFN-␥ results in severe tissue damage and wasting of the host (Thomsen et al., in press ). This is because the replication rate of this strain is fast, resulting in CTL-induced pathology unless the replication kinetics are reduced by soluble immune mediators.
CTL-induced pathology and CD4 cell depletion in HIV infection
In the above sections we determined that occurrence of CTL-induced pathology does not require the virus to be noncytotoxic, but is likely to be observed if viral cytotoxicity is low relative to the rate of viral replication. Thus, if HIV replicates at a fast rate, then CTL might contribute to pathology even if HIV also directly kills the cell. If CTL-induced pathology is a determinant of HIV disease progression, we must explain how this is possible provided that HIV completes its replication cycle only in activated T cells, a restricted subset of the overall CD4 T cell population (Heinzinger et al., 1994; Stevenson, 1994 Stevenson, , 1996 Stevenson et al., 1995) . In order to examine this paradox, we extend the above model to account for the interactions among HIV, CD4 T cells, and the CTL response. The model consists of five variables: resting uninfected CD4 T cells, s, activated uninfected T cells, x, infected T cells, y, free virus, v, and CTL, z. In contrast to the basic virus infection model we assume that HIV completes it replication cycle only in activated CD4 T cells and that T cell activation occurs in response to viral antigen. This can include bystander activation resulting from the high viral load observed in primary infection. The model is explained graphically in Fig. 1 .
The exact mathematical consequences of assuming that only activated T cells become infected are set out in detail in Wodarz et al. (1999a) . Here we are interested in whether CTL-mediated pathology can lead to a depletion of the overall CD4 T cell count at equilibrium. In the previous section we found that CTL-induced pathology is the consequence of fast viral replication relative to the CTL responsiveness of the host. In the current model we must break down the overall replication rate of the virus into the rate of virus production and the rate of entry into susceptible target cells. If the rate of virus production is fast relative to the CTL responsiveness of the host, the number of uninfected activated and resting CD4 T cells is reduced to very low numbers, and the CTL response 
FIG. 2.
Basic properties of CTL-induced pathology, defined by a reduction of the total number of target cells in the presence of CTL, compared to the absence of CTL. We assume that the virus is noncytopathic. CTL-induced pathology is most likely to occur at a low or intermediate efficacy of the CTL response (c ϫ p). In addition, the replication rate of the virus plays an important role. The faster the replication kinetics of the virus, the more severe the degree of pathology observed. If the virus replicates at a fast rate, a significant reduction in the total number of target cells will be observed even in the presence of a relatively strong CTL response. If the virus replicates slowly, any degree of immunopathology is observed only in the presence of inefficient CTL. Thus, for slowly replicating viruses, an increase in the CTL responsiveness is likely to benefit the host, while for faster replicating strains, the opposite applies (see vertical dashed line and arrows). Parameters were chosen as follows:
suppresses the number of infected cells (see Materials and Methods). This immunopathology can lead to the depletion of the T helper cell pool. The reason is that a fast rate of virus production results in higher levels of free virions exposed to the immune system. This in turn results in a higher degree of T cell activation that enables the virus to infect cells. Continuous activation of the resting CD4 T cell pool, in combination with infection and CTL-mediated killing, can lead to depletion of the overall T helper cell population.
On the other hand, if the rate of virus entry into susceptible cells is large relative to the CTL responsiveness of the host, the situation is more complicated (see Materials and Methods). The CTL response suppresses the number of infected T helper cells, and the high rate of virus entry results in low numbers of activated uninfected CD4 T cells. Whether the number of resting CD4 T cells is also depleted depends on the exact assumptions underlying the term describing T cell activation. The resting T cell pool is depleted only if the rate of T cell activation significantly increases when the number of activated T cells falls to low levels, i.e., for low ⑀. This assumes the presence of a feedback mechanism acting on the level of activated CD4 T cells. While this is a mathematical possibility, the biological interpretation of this mechanism remains uncertain and should therefore be treated with some skepticism.
To summarize, a fast rate of viral replication (especially virion production) relative to the CTL responsiveness of the host results in immunopathological depletion of the CD4 T cell pool even when the virus infects only activated T cells and if the virus is cytotoxic to a certain degree. A fast rate of virion production relative to the CTL responsiveness results in CTL-induced pathology, while the effect of a fast rate of viral entry on the degree of immunopathology depends on the exact assumptions underlying the T cell activation term.
HIV dynamics in the absence of CTL
It has been suggested that therapeutic reduction of the number of HIV-specific CTL could be beneficial for the patient, especially if the virus is noncytopathic (Zinkernagel, 1994 (Zinkernagel, , 1995 Zinkernagel and Hengartner, 1994 ). Here we examine whether or not the absence of a CTL response would be advantageous for the host assuming for now that the virus is noncytopathic. The answer depends on the life span of activated T cells relative to resting CD4 T cells. For fast viral replication kinetics, the model predicts that the sum of infected and uninfected T cells in the absence of a lytic CTL response is approximately /d, that is, the production rate of resting cells divided by the death rate of activated T cells. In the absence of the infection, the total number of CD4 T cells is given by /f, where f is the death rate of resting CD4 T cells. Thus, if the death rate of activated T cells is significantly higher than that of resting T cells (d ӷ f ), a fast rate of viral replication in the absence of a CTL response can still produce a reduction of the CD4 T cell count. For example, the CD4 T cell count can be reduced from 1000 to 200 if the death rate of activated cells is five times higher than that of resting T cells. This is true if the rate of virion production is fast and might also hold for fast rates of viral entry into host cells given the restrictions discussed in the previous section.
Note that this result has important implications for the design of experiments to test possible mechanisms responsible for T cell depletion in HIV infection. One way to test whether viral cytopathicity contributes to a reduction of the CD4 cell population is to deplete macaques of CD8 T cells (Schmitz et al., 1999) and to follow CD4 T cell counts during primary infection. Our model predicts that even if HIV were noncytopathic and the host depleted of CD8 T cells, depletion of the T helper cell pool can still be observed. This is because viral replication can activate a large number of T cells, and activated T cells have a short life span.
HIV disease progression and virus evolution
Experimental data indicate that disease status and disease progression in HIV-infected patients correlate with the rate of viral replication. It has been found that slow disease progression is associated with the presence of slowly replicating virus strains, e.g., due to a deletion in nef (Deacon et al., 1995; Miller and Greene, 1996) . Moreover, at the beginning of the asymptomatic period, slowly replicating strains dominate the virus population while the replication kinetics of the virus increase during disease progression until the development of AIDS (Asjo et al., 1986; Connor and Ho, 1994; Fenyo et al., 1988; Ferbas et al., 1996; Gruters et al., 1991; Tersmette et al., 1989) .
Recent empirical (Kalams et al., 1999a; Kalams and Walker, 1998; Lifson et al., 2000; Rosenberg et al., 1997 Rosenberg et al., , 1999 Rosenberg and Walker, 1998) and theoretical studies (Wodarz et al., 1999b,c; Wodarz and Nowak, 1999) have revealed the importance of the dynamical interactions occurring during primary infection for the immune system to control viral replication in the long term. The high virus load typically observed during the primary phase is thought to induce impairment of T helper cells, which in turn results in the failure to establish an efficient CTL memory response (Borrow et al., 1996 (Borrow et al., , 1998 Kalams et al., 1999b; Kalams and Walker, 1998; Thomsen et al., 1996 Thomsen et al., , 1998 .
Hence, infected patients could be faced by fast-replicating virus strains and a relatively weak CTL response. This is the parameter region in which T cell depletion induced by CTL-mediated lysis is likely to occur. Thus, CTL-induced pathology could contribute to the development of AIDS. Note that this does not require the as-sumption that HIV is noncytopathic. These dynamics are compatible with the assumption that HIV can be cytopathic in T cells, given that the rate of viral replication is sufficiently fast.
According to this argument, evolution toward faster replicating HIV strains could be a major driving force underlying progression to AIDS. However, given the high mutation rate of HIV (Bebenek et al., 1989; Nowak, 1990; Roberts et al., 1988) , it is hard to explain why it takes such a long time to develop AIDS. The virus population would be expected to evolve to sufficiently fast replication kinetics in a shorter period of time, and pathology should set in earlier. In order to account for the delay in disease progression we must expand the model by introducing further details regarding the replication cycle of HIV. We address this problem in the next section.
An evolutionary model of HIV coreceptor usage
Here we introduce a model taking into account the tropism of HIV for the CCR5 and CXCR4 coreceptors, as well as the susceptibility of virus strains with different tropisms to lytic and nonlytic CTL responses. CCR5 tropic HIV strains can infect both macrophages and primary CD4 T cells. CXCR4 tropic HIV can infect CD4 T cells only. Sequence analysis of synonymous and nonsynonymous mutations suggests that the lytic CTL response is less efficient against infected macrophages compared to T cells (Bonhoeffer et al., 1995) . On the other hand, in contrast to CXCR4-tropic HIV, CCR5-tropic strains are inhibited by CD8 T-cell-secreted ␤-chemokines. Thus, a switch to CXCR4 tropism is equivalent to an increase in the death rate of infected cells, as well as to escape from nonlytic CD8 responses. We capture these assumptions in our model. It is described schematically in Fig. 1 , and mathematical details are found under Materials and Methods.
Model predictions
In this model, significant levels of CD4 T cell depletion due to CTL-induced pathology are likely only if HIV has largely escaped nonlytic CD8 cell-mediated activity, for example, by switching to CXCR4 tropism. This is because chemokines strongly reduce the replication kinetics of the virus and therefore counter immunopathological effects. In the following we examine how the evolution of coreceptor usage depends on viral and host parameters. In contrast to the previous sections, here we allow the virus population to evolve new cell tropisms under immune selection pressures. Preference for the CXCR4 and CCR5 coreceptors is captured in the parameter q and is treated as a continuous trait varying between 0 and 1. The higher the value of q, the higher the tropism for CCR5 and the lower the tropism for CXCR4. A value of q ϭ 0 corresponds to specialization on CXCR4, while q ϭ 1 corresponds to specialization on CCR5. We analyze how changes in the rate of viral replication influence the evolutionary dynamics of coreceptor usage. We call the level of coreceptor usage (q) to which the virus population evolves the evolutionarily stable state. Figure 4 shows the evolutionarily stable state of coreceptor usage depending on the viral replication rate. We consider the rate of target cell entry (␤), although changing the rate of virion production by infected cells (k) has an identical effect. Assuming that the rate of viral replication is fast enough to allow T cell infection (Wodarz et al., 1999a) , increasing the replication rate of HIV results in evolution toward higher degrees of CCR5 tropism. Above we established that CTL-induced pathology requires relatively fast replication kinetics of HIV in combination with CXCR4 tropism. Since fast replication favors the evolution toward CCR5 tropism, infection is inhibited by nonlytic CD8 cell responses and pathology can be prevented. In the context of these results, how can fast-replicating virus strains evolve toward CXCR4 tropism? This is facilitated by a high rate of T cell activation in response to antigen, 1 (Fig. 4) . In biological terms, this can be achieved through an accumulation of opportunistic infections in the face of HIV-induced immune subversion (Phair, 1999) .
To summarize, the model predicts a long time span until AIDS develops as a result of CTL-induced pathology. Pathology requires a fast rate of viral replication combined with the evolution of CXCR4 tropic strains. However, a fast rate of viral replication tends to lead to the evolution of CCR5 tropic strains that are efficiently inhibited by CTL-secreted ␤-chemokines.
FIG. 4.
The degree of coreceptor usage of HIV evolves depending on the rate of viral infectivity, ␤, and the rate of CD4 T cell activation, 1 . The result is the same when changing the rate of virion production, k. The faster the rate of viral replication, the higher the degree of CCR5 tropism seen in the HIV population. Evolution of HIV strains that are more CXCR4 tropic and replicate at a fast rate is observed if the rate of CD4 T cell activation ( 1 ) is high. This can be caused by an accumulation of persistent pathogens during the asymptomatic phase of the infection. Parameters were chosen as follows: 2 ϭ 10; d 1 ϭ 0.1; d 2 ϭ 0.1; a 1 ϭ 0.1; a 2 ϭ 0.1; k ϭ 1; u ϭ 1; c ϭ 0.2; b ϭ 0.1; p 1 ϭ 10; p 2 ϭ 1.
Conclusion
We used mathematical models to study properties of CTL-induced pathology in viral infections. The models allow us to precisely define pathology and to explore the dynamical interactions that could eventually result in disease. The basic results are summarized in Table 1 . CTL-induced pathology not only occurs with noncytopathic viruses, but is likely to be observed if viral cytopathicity is low relative to the replication kinetics of the virus. CTL-induced pathology is promoted by a fast rate of viral replication relative to the CTL responsiveness of the host. While the CTL suppress the number of infected cells, viral replication reduces the number of uninfected cells to low levels. If the CTL response is sufficiently strong to overcome the rate of viral replication, then the CTL are beneficial to the host and resolve the infection without the occurrence of significant tissue damage. These results are in good agreement with experimental studies on CTL-induced pathology in LCMV infection.
The finding that a fast rate of viral replication relative to the CTL responsiveness of the host promotes CTL-induced pathology also holds true for HIV infection. We have explored specific mathematical models to investigate the role of CTL-induced pathology in the context of HIV infection. The role of virus-induced cell killing versus host-induced cell killing is still a controversial area of research (Krakauer and Payne, 1997) . Our models suggest that in a setting of relatively weak CTL-mediated immunity and fast viral replication, CTL-induced pathology is likely to contribute to CD4 T cell depletion, even if HIV is to a certain degree cytotoxic. Experimental data on the rate of viral replication and the efficacy of the immune response in HIV infection are consistent with the theoretical results presented here. Note, however, that our models do not suggest that CTL-induced pathology is the overriding factor responsible for disease progression. Indeed, in the setting of fast viral replication, direct viral cytotoxicity can also contribute to depletion of the T cell pool. However, our models do suggest that a combination of both mechanisms contributes to disease progression.
If CTL-induced pathology does contribute to disease progression, it has been suggested that elimination of HIV-specific CTL might be beneficial for the host (Zinkernagel, 1994 (Zinkernagel, , 1995 Zinkernagel and Hengartner, 1994) . However, our mathematical models caution against this strategy. They suggest that the safest way in which to prevent progression to AIDS is to induce a CTL response of sufficient strength to overcome the replication rate of the virus. Fast viral replication in the absence of a CTL response is likely to result in CD4 T cell depletion through natural attrition of activated T cells.
Finally, the more detailed model describing the interaction between HIV coreceptor usage and lytic and nonlytic CTL responses provides some insight into the relatively long time span required for the development of AIDS. While a fast rate of viral replication is required for CTL-induced pathology, fast replication kinetics favor evolution of CCR5 tropism and therefore successful chemokine-mediated prevention of disease. We suggest that a high rate of CD4 T cell activation in response to the accumulation of persistent opportunistic pathogens over time is required to result in the evolution of fast-replicating and CXCR4 tropic variants and hence in the development of disease. This is consistent with the empirical finding that in advanced HIV disease, shorter survival is associated with increased levels of T lymphocyte activation (Giorgi et al., 1999) .
Again, it is important to note that these evolutionary dynamics hold true even if viral cytotoxicity contributes to disease development. These dynamics must be considered in a more general framework where viral evolution is a driving force in HIV disease progression. Mathematical models suggest that evolution toward increased viral replication and toward higher degrees of antigenic diver- 
Model Predictions
Basic properties of CTL-induced pathology (e.g., in LCMV infection)
• CTL-mediated pathology occurs if the sum of uninfected and infected cells is smaller in the presence of a CTL response than in the absence of CTL; CTL-induced pathology is observed if the rate of viral replication is fast relative to the CTL responsiveness of the host CD4 cell infection and CTL-induced pathology (HIV)
• Fast viral replication can induce depletion of the CD4 T cell pool
• The absence of a CTL response can also lead to CD4 T cell depletion, even if the virus is noncytopathic, becuase of the short life span of activated relative to resting T cells • CTL-induced pathology can be avoided only by increasing the efficacy of the CTL response sufficiently to overcome viral replication and not by depleting virus-specific CTL Evolution of HIV coreceptor usage and disease progression
• In vivo evolution of HIV toward fast replication results in virus evolution to CCR5 usage; such strains are inhibited by ␤-chemokines preventing disease • This can account for the long time span required to develop disease: AIDS as a result of CTL-induced pathology is likely to develop only if the rate of T cell activation is increased, e.g., by the accumulation of persistent pathogens sity can result in a gradual deterioration of antiviral immunity, which eventually culminates in the collapse of the CD4 T cell population and the development of AIDS (de Boer and Boerlijst, 1994; Nowak et al., 1991 Nowak et al., , 1995 Regoes et al., 1998; Wodarz et al. (1998) . These models explicitly take into account the ability of the virus to impair immune responses, for example, by killing CD4 T cells. However, as discussed in the present paper, similar conclusions can be attained if the CTL are responsible for T cell depletion, even when HIV is cytotoxic to a degree. Hence, further experimental work is required to precisely define the role of virus-induced versus hostinduced T cell killing for HIV disease progression.
MATERIALS AND METHODS

Basic dynamics between virus and CTL
The basic model describing the interactions between a replicating virus population and a specific antiviral CTL response takes into account four variables: uninfected cells, x, infected cells, y, virus, v, and CTL, z. It is given by the following set of differential equations:
Uninfected cells are produced at a rate , die at a rate dx, and become infected at a rate ␤xv. Infected cells die at a rate ay, produce virions at a rate ky, and are lysed by CTL at a rate pyz. Free virus particles decay at a rate uv. The CTL population expands at a rate cy and decays at a rate bz. When modeling CTL dynamics, the exact functional response used to study CTL expansion is an important issue. Various models have been used in the theoretical literature. Thus, Nowak and Bangham (1996) used a response where CTL expansion was proportional to the number of CTL. While this more accurately describes the process of CTL proliferation, it lacks a saturation term. As a consequence, equilibrium virus load is determined only by a restricted set of immunological parameters, and the CTL population grows to ever-increasing values if the rate of CTL-mediated killing, p, is low. The functional response used in the present paper is an alternative, simply describing CTL expansion in response to the presence of antigen. In this case, equilibrium virus load is determined by a combination of host and viral parameters. The consequence of different functional responses to describe CTL dynamics has been analyzed and compared in detail by de Boer and Perelson (1998) and Wodarz et al. (2000) .
If the basic reproductive ratio of the virus (R 0 ϭ ␤/ da) is greater than unity, the system converges to an equilibrium describing persistent virus replication in the presence of a CTL response. It is given by E1.
where x ͑1͒ is given by
We define ␤Ј ϭ ␤k/u.
HIV dynamics and T cell activation
The model describing the interactions between CD4 T cells, HIV, and the CTL response takes into account five variables: resting uninfected CD4 T cells, s, activated uninfected T cells, x, infected T cells, y, free virus, v, and CTL, z. It is given by the following set of differential equations:
We assume that HIV infects only activated T cells and that the virus induces CD4 cell activation. Resting CD4 T cells are produced at a rate , die at a rate fs, and become activated by virus at a rate rsv/( x ϩ ⑀). This assumes that the rate of T cell activation is a function of the number of T cells that are already activated. If ⑀ is small, the rate of T cell activation significantly increases if the number of activated T cells is low. Activated T cells die at a rate dx and become infected at a rate ␤xv. Infected cells produce free virus at a rate ky, die at a rate ay, and are killed by CTL at a rate pyz. Free virus decays at a rate uv. The CTL population expands in response to antigen at a rate cy and decays at a rate bz. Persistent virus replication in the presence of a CTL response is described by an equilibrium given by a third-degree polynomial expression, which we omit to include for aesthetic reasons. In this model, a fast rate of viral replication relative to the efficacy of the CTL response results in depletion of uninfected activated T helper cells at equilibrium, while the CTL suppress the number of infected cells. The number of resting cells at equilibrium is given by s* ϭ /[ f ϩ rv*/( x* ϩ ⑀)], where x* and v* denote the equilibrium number of uninfected activated T cells and the equilibrium level of free virus, respectively. An increase in the rate of virion production, k, results in an increase in v* and a decrease in x*. This can lead to depletion of the number of resting T cells. An increase in the rate of target cell entry, ␤, results only in a decrease in x*. Hence, whether the resting T cell pool can be depleted by a high value of ␤ depends on the value of ⑀. In biological terms, a low value of ⑀ indicates increased rates of T cell activation if the number of activated T cells is low. If such a feedback mechanism is involved in regulating T cell activation, an increase in the rate of target cell entry, ␤, can lead to a depletion of the resting T helper cell pool. However, in biological terms it is not possible to tell whether such a feedback mechanism exists and we include it for completeness, as it remains a possibility.
Modeling viral evolution
The model describing the evolutionary dynamics of coreceptor usage in HIV infection includes six variables: uninfected T cells, x 1 , uninfected macrophages, x 2 , infected T cells, y 1 , infected macrophages, y 2 , free virus, v, and CTL, z. It is given by the following set of differential equations:
The parameter q␤ denotes the rate of entry into cells bearing the CCR5 coreceptor. We assume that increased tropism for one coreceptor is associated with decreased tropism for the other (Scarlatti et al., 1997) . Thus, the rate of infection of cells bearing the CXCR4 coreceptor is given by (1 Ϫ q)␤. Uninfected susceptible (i.e., activated) T cells are generated in response to antigen at a rate 1 v/(⑀v ϩ 1) and die at a rate d 1 x 1 . They may be infected by virus using either the CCR5 coreceptor at a rate q␤x 1 v or the CXCR4 receptor at a rate (1 Ϫ q)␤x1v. Uninfected macrophages are produced at a rate 2 , die at a rate d 2 x 2 , and become infected by CCR5 tropic virus only at a rate q␤x 2 v. Infected T cells and macrophages die at a rate a 1 y 1 and a 2 y 2 , respectively. Free virus is produced by the infected cells at a rate k( y 1 ϩ y 2 ) and decays at a rate uv. The CD8 T cell population expands in response to infected cells at a rate c( y 1 ϩ y 2 ) and decays at a rate bz. The CD8 T cells have both lytic and nonlytic activities. The model assumes that significant lytic activity occurs only against infected T cells at a rate p 2 y 1 z. Nonlytic activity inhibits virus entry into cells bearing the CCR5 receptor at a rate p 1 z ϩ 1. Infection of CXCR4-expressing T cells is not inhibited by nonlytic CD8 cell-mediated activity. The dynamical properties of this model are explored numerically. The evolutionarily stable state of coreceptor usage (q) for different host and viral parameters was found as follows: Given that a specific virus strain, characterized by a certain value q, has established a persistent infection and has equilibrated, we checked for invasion with a virus strain that has mutated to a different value of q. If the mutant could invade, it was further determined whether this led to replacement of the previous strain or to a coexistence equilibrium. This procedure was iterated until an equilibrium was found that could not be invaded by any alternative strains.
